Cision PR Newswire

Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy

Paxalisib Monotherapy Significantly Reduced Tumor Burden in Pre-Clinical Model of MSS/pMMR Colorectal Cancer, With the Addition of Pembrolizumab Driving a Further Reduction Paxalisib Was...

DermRays Celebrates International Women’s Day with the Launch of the FusionGlow and Exclusive Discounts for Women

PLEASANTON, Calif., March 1, 2025 /PRNewswire/ -- In honor of International Women's Day, DermRays is excited to announce the launch of its latest innovation, the FusionGlow...

MiL.k migrates to Arbitrum for the full-scale expansion of global web3 business

- MiL.k decided to onboard on Arbitrum for accelerating its global business expansion- Arbitrum is the leading Ethereum layer 2 solution for various dApps and...

Zeekr Group Announces February 2025 Delivery Update

HANGZHOU, China, March 1, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new...